- Joined
- Jul 16, 2008
- Messages
- 31,114
- Points
- 113
MOH does not make info on this matter clear, as evidenced by the differing contrasting answers given by different AIs. MOH sucks.
Google AI:
No, you cannot use MediSave to pay for the shingles vaccine if you do not meet the age or medical condition criteria.
The Ministry of Health (MOH) restricts the use of MediSave for adult vaccinations strictly to individuals who fall within the approved target groups under the National Adult Immunisation Schedule (NAIS).
MediSave Restrictions & Rules
Grok AI:
Yes, Medisave can generally be used for the shingles vaccine (Shingrix) in Singapore even if you are not eligible for age-based (60+) or medical condition (immunocompromised) subsidies, especially from mid-2026 onwards.
Current Situation (as of June 2026)
For non-subsidised patients (those outside the recommended groups), several private clinics explicitly state that Medisave can cover the full retail price (around $370 per dose, or ~$700–$900 for the two-dose course, before any clinic markups). This is because the vaccine is now integrated into the broader outpatient MediSave framework for approved vaccinations.
Google AI:
No, you cannot use MediSave to pay for the shingles vaccine if you do not meet the age or medical condition criteria.
The Ministry of Health (MOH) restricts the use of MediSave for adult vaccinations strictly to individuals who fall within the approved target groups under the National Adult Immunisation Schedule (NAIS).
MediSave Restrictions & Rules
- The Eligibility Requirement: To use your MediSave (via MediSave500/700 or Flexi-MediSave) for the Shingrix vaccine, you must meet the NAIS criteria: aged 60 years and above, OR aged 18 to 59 with specific immunocompromising medical conditions.
- The Policy for "Out-of-Scope" Patients: If you choose to get vaccinated as a elective or preventive measure outside of these specific demographics, you are considered "non-subsidised" and must pay out-of-pocket using cash or card.
Grok AI:
Yes, Medisave can generally be used for the shingles vaccine (Shingrix) in Singapore even if you are not eligible for age-based (60+) or medical condition (immunocompromised) subsidies, especially from mid-2026 onwards.
Current Situation (as of June 2026)
- Subsidies are limited to recommended groups under the National Adult Immunisation Schedule (NAIS): adults aged 60+ and immunocompromised adults aged 18–59. These are available at CHAS GP clinics, polyclinics, and selected MOH-funded providers since September 2025.
- Medisave usage was extended alongside this. From around mid-2026 (some sources mention 1 June 2026), you can use MediSave500/700 (up to $500–$700 per year depending on conditions) to pay for the vaccine. Seniors 60+ may also use Flexi-MediSave.
For non-subsidised patients (those outside the recommended groups), several private clinics explicitly state that Medisave can cover the full retail price (around $370 per dose, or ~$700–$900 for the two-dose course, before any clinic markups). This is because the vaccine is now integrated into the broader outpatient MediSave framework for approved vaccinations.